Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Gynecologic Oncology Trial and Investigation Consortium (GOTIC) is a prominent Japanese clinical research organization dedicated to improving the standard of care for gynecologic cancers. Founded in 2002, GOTIC facilitates high-quality multicenter clinical trials by collaborating with academic institutions and global pharmaceutical companies. The consortium's research portfolio includes significant studies in ovarian, cervical, and endometrial cancers, focusing on the evaluation of immunotherapies, targeted therapies, and novel chemotherapy combinations. GOTIC plays a critical role in the global oncology landscape as a member of the Gynecologic Cancer InterGroup (GCIG), providing robust clinical data that informs international treatment guidelines. The organization operates as a non-profit entity, leveraging a vast network of participating hospitals across Japan to accelerate the development of life-saving treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gynecologic Oncology Trial and Investigation Consortium.